Beatriz Arbaizar
Research Subjects
Beatriz Arbaizar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Inés Gómez-Acebo
Department of Preventive Medicine and Public Health, University of Cantabria, Santander, Spain
3 shared publications - Javier Llorca
Cátedra de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Cantabria, Santander
2 shared publications - Trinidad Dierssen-Sotos
Preventive Medicine Group, University of Cantabria, IDIVAL-Valdecilla Health Research Institute, Santander, Spain; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
2 shared publications Javier Llorca
1 shared publication- Javier Llorca
IMDEA Materials Institute, Madrid, Spain
1 shared publication
Latest Publications
- 1 November 2011
- Vol. 39 (6) , 401-3
[Fucus vesiculosus induced hyperthyroidism in a patient undergoing concomitant treatment with lithium].
Fucus vesiculosus is a marine alga rich in iodine, which is being used in alternative medicine as a laxative, diuretic, and as a complement for weight loss diets. We report the case of a 60-year old male patient, diagnosed with bipolar disorder and under treatment with lithium concomitantly with a herbal preparation, including Fucus vesiculosus, as a laxative. He developed hyperthyroidism that remitted once the herbal preparation was withdrawn. Fucus vesiculosus may cause hyperthyroidism given its high iodine content. Herbal preparations should be taken in account when treating a patient due to the possibility of adverse effects and interactions with other drugs.
- 1 November 2011
- Vol. 39 (6) , 401-3
[Fucus vesiculosus induced hyperthyroidism in a patient undergoing concomitant treatment with lithium].
Fucus vesiculosus is a marine alga rich in iodine, which is being used in alternative medicine as a laxative, diuretic, and as a complement for weight loss diets. We report the case of a 60-year old male patient, diagnosed with bipolar disorder and under treatment with lithium concomitantly with a herbal preparation, including Fucus vesiculosus, as a laxative. He developed hyperthyroidism that remitted once the herbal preparation was withdrawn. Fucus vesiculosus may cause hyperthyroidism given its high iodine content. Herbal preparations should be taken in account when treating a patient due to the possibility of adverse effects and interactions with other drugs.
- 31 August 2010
- Published by Elsevier in General Hospital Psychiatry
- Vol. 32 (4) , 449
Comments on “Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.” Authors' response
- 31 August 2010
- Published by Elsevier in General Hospital Psychiatry
- Vol. 32 (4) , 449
Comments on “Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.” Authors' response
- 31 October 2009
- Published by Elsevier in General Hospital Psychiatry
- Vol. 31 (5) , 478-483
Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials
- 31 October 2009
- Published by Elsevier in General Hospital Psychiatry
- Vol. 31 (5) , 478-483
Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials
- Open Access
- 11 June 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 198
Decrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report
Introduction: A large part of research into drug addiction focuses on mesolimbic dopamine circuitry; however, both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and/or kainate and dopamine D2 receptors can play a role in maintaining the established addiction.Case presentation: We report the case of a 34-year-old man who compulsively smoked 80 to 100 cigarettes each day. After receiving treatment with topiramate and aripiprazole, his tobacco consumption was dramatically reduced.Conclusion: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and/or kainate blocking agents and a dopamine D2 receptor partial agonist may be novel instruments for nicotine abuse disorders.
- 11 June 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 198
Open AccessDecrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report
Introduction: A large part of research into drug addiction focuses on mesolimbic dopamine circuitry; however, both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and/or kainate and dopamine D2 receptors can play a role in maintaining the established addiction.Case presentation: We report the case of a 34-year-old man who compulsively smoked 80 to 100 cigarettes each day. After receiving treatment with topiramate and aripiprazole, his tobacco consumption was dramatically reduced.Conclusion: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and/or kainate blocking agents and a dopamine D2 receptor partial agonist may be novel instruments for nicotine abuse disorders.